Evidence map›Paper›PMID 21547394›Full record

ArticleJournal of clinical immunology2011

TNFRSF13B/TACI alterations in Greek patients with antibody deficiencies.

Matthaios Speletas, Antigoni Mamara, Efimia Papadopoulou-Alataki, George Iordanakis, Kyriaki Liadaki, Fotini Bardaka, Maria Kanariou, Anastasios E Germenis

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of clinical immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Avicenna journal of medical biotechnology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Matthaios SpeletasDepartment of Immunology and Histocompatibility, University of Thessaly Medical School, Larissa, 41500, Greece. maspel@med.uth.gr
Antigoni Mamara
Efimia Papadopoulou-Alataki
George Iordanakis
Kyriaki Liadaki
Fotini Bardaka
Maria Kanariou
Anastasios E Germenis
University of Thessaly · GRAristotle University of Thessaloniki · GRChildren's Hospital Agia Sophia · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

TNFRSF13B/TACI defects have recently been associated with common variable immunodeficiency (CVID) pathogenesis. Considering that TNFRSF13B/TACI is very polymorphic and the frequency of its alterations may be different in various ethnic groups, we analyzed their prevalence in 47 Greek patients with antibody deficiencies, including CVID (16 patients), IgAD (16 patients), selective IgG4D (11 patients), and transient hypogammaglobulinemia of infancy (4 patients). A rather high frequency of TNFRSF13B/TACI defects was identified in patients with selective IgG4D (18.18%). Moreover, a patient with CVID was heterozygous in the common C104R mutation (6.25%). Both his children and a further healthy individual carried the same mutation, albeit without recurrent infections and/or hypogammaglobulinemia. The common polymorphisms V220A and P251L were identified in all disease subgroups, in an almost similar frequency with that observed in 259 healthy controls. Our data provide further evidence that TNFRSF13B/TACI alterations are not causative of CVID. Possibly, they predispose to humoral deficiencies and/or contribute to their phenotype when combined with other immune gene alterations.

Indexed as

IgA DeficiencyIgG DeficiencyAdolescentAdultAgammaglobulinemiaAgedAged, 80 and overChildChild, PreschoolCommon Variable ImmunodeficiencyFemaleGenetic Predisposition to DiseaseGreeceHumansImmunoglobulin AImmunoglobulin GImmunoglobulin AImmunoglobulin GTNFRSF13B protein, humanTransmembrane Activator and CAML Interactor Protein

Identifiers

PMID21547394
OpenAlexW2036626029

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.